Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Compier Literature Screening is an AI-powered platform aimed at helping pharmacovigilance experts streamline the process of reviewing abstracts, full texts, and translated articles to uncover pertinent information about patients, authors, events, products, and safety-related data. This innovative platform seamlessly connects with various online biomedical databases, including Medline, and allows users to upload literature records in bulk from multiple sources like Embase, conference presentations, and PDF journals. It conducts automated duplicate checks for every literature search and employs validated AI models for the automatic screening and annotation of key entities. Users have the flexibility to set up scalable literature screening workflows that meet their unique needs and comply with international regulations. The system enhances collaboration with external vendors to secure full texts and comes equipped with translation capabilities. Additionally, it integrates smoothly with safety systems, such as Oracle Argus Safety, to share articles relevant to Individual Case Safety Reports (ICSRs), thereby ensuring comprehensive safety monitoring. The platform ultimately seeks to improve the overall efficiency and accuracy of pharmacovigilance activities.
Description
DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine PV processes and manage safety information more efficiently. The platform brings together global and local literature monitoring, regulatory intelligence, and adverse event management in one connected workflow.
DrugCard supports PV teams in identifying relevant safety information faster, reducing manual screening workload, and maintaining transparent, audit-ready processes. Its literature monitoring module covers 121+ countries, 2,200+ local medical sources, and 100+ languages, including both global databases such as PubMed and local, non-indexed medical journals.
The platform uses AI to support article pre-assessment, generate structured summaries, highlight relevant keywords, assist with translations, and help users prioritize publications that may require safety review. DrugCard also provides configurable workflows, automated notifications, reporting tools, QC functionality, audit trails, and case creation from literature.
With additional modules for Regulatory Intelligence and Adverse Event Database management, DrugCard helps organizations track health authority updates, centralize safety data, support E2B workflows, and improve overall pharmacovigilance operations. Built for MAHs, QPPVs, LQPPVs, CROs, regulatory teams, and PV professionals, DrugCard combines automation with human expert oversight to support compliant, scalable, and reliable drug safety management.
API Access
Has API
API Access
Has API
Integrations
MEDLINE
Oracle Argus
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
individual
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Techsol Life Sciences
Founded
2010
Country
Techsol Life Sciences
Website
www.techsollifesciences.com/pharmacovigilance/compier-literature-screening/
Vendor Details
Company Name
DrugCard
Founded
2021
Country
Estonia
Website
drug-card.io